CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000KH21DF8

Market Closed - Deutsche Boerse AG 13:41:21 2024-06-14 EDT
39.94 EUR +0.03% Intraday chart for CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+0.25%
1 month+0.63%
Date Price Change
24-06-14 39.94 +0.03%
24-06-13 39.93 +0.03%
24-06-12 39.92 0.00%
24-06-11 39.92 +0.03%
24-06-10 39.91 +0.03%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 01:41 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Citi Citi
WKN KH21DF
ISINDE000KH21DF8
Date issued 2023-01-30
Strike 40
Maturity 2024-06-20 (4 Days)
Parity 1 : 1
Emission price 31.6
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 39.96
Lowest since issue 31.53

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.63 EUR
Average target price
39.97 EUR
Spread / Average Target
+3.48%
Consensus